Author:
Kocis Paul T.,Liu Guodong,Makenbaeva Dinara,Trocio Jeffrey,Velott Diana,Trainer JoAnn B.,Abdulsattar Younos,Molina Marta I.,Leslie Douglas L.
Funder
Pfizer (US)
Bristol-Myers Squibb (US)
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC, Priori SG, Estes NA, Ezekowitz MD, Jackman WM, January CT, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Hochman JS, Kushner FG, Ohman EM, Tarkington LG, Yancy CW, Force ACoCFAHAT. 2011 accf/aha/hrs focused updates incorporated into the acc/aha/esc 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2011;123:e269–367.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the framingham study. Stroke. 1991;22:983–8.
3. Iwasaki K, Pyenson B. Milliman Client Report: Non-valvular atrial fibrillation & anticoagulation therapy: an acturial study of the medicare population. August, 2010. Retrieved http://us.milliman.com/uploadedFiles/insight/research/health-rr/non-valvular-atrial-fibrillation.pdf Accessed 13 Mar 2016.
4. Lip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med. 2010;123:484–8.
5. Casciano JP, Singer DE, Kwong WJ, Fox ES, Martin BC. Anticoagulation therapy for patients with non-valvular atrial fibrillation. Am J Cardiovasc Drugs. 2012;12:313–23.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献